These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 33259623)

  • 41. Influence of functional food components on gut health.
    Wan MLY; Ling KH; El-Nezami H; Wang MF
    Crit Rev Food Sci Nutr; 2019; 59(12):1927-1936. PubMed ID: 29381385
    [TBL] [Abstract][Full Text] [Related]  

  • 42. THE PRESENT AND FUTURE OF PERSONALIZED NUTRITION.
    Torres N; Tovar AR
    Rev Invest Clin; 2021; 73(5):321-325. PubMed ID: 34609363
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of Prebiotics on Enteric Diseases and Oxidative Stress.
    Gao J; Azad MAK; Han H; Wan D; Li T
    Curr Pharm Des; 2020; 26(22):2630-2641. PubMed ID: 32066357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of the microbiome for human health: from basic science to clinical applications.
    Mohajeri MH; Brummer RJM; Rastall RA; Weersma RK; Harmsen HJM; Faas M; Eggersdorfer M
    Eur J Nutr; 2018 May; 57(Suppl 1):1-14. PubMed ID: 29748817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nutritional Modulation of Innate Immunity: The Fat-Bile-Gut Connection.
    Chevre R; Silvestre-Roig C; Soehnlein O
    Trends Endocrinol Metab; 2018 Oct; 29(10):686-698. PubMed ID: 30197155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential role of the intestinal microbiota in programming health and disease.
    Goulet O
    Nutr Rev; 2015 Aug; 73 Suppl 1():32-40. PubMed ID: 26175488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature.
    Milosevic I; Vujovic A; Barac A; Djelic M; Korac M; Radovanovic Spurnic A; Gmizic I; Stevanovic O; Djordjevic V; Lekic N; Russo E; Amedei A
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Engineering the Gut Microbiome for Treatment of Obesity: A Review of Current Understanding and Progress.
    Lim YY; Lee YS; Ooi DSQ
    Biotechnol J; 2020 Oct; 15(10):e2000013. PubMed ID: 32663372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathophysiological role of host microbiota in the development of obesity.
    Kobyliak N; Virchenko O; Falalyeyeva T
    Nutr J; 2016 Apr; 15():43. PubMed ID: 27105827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation].
    Aitbaev KA; Murkamilov IT; Fomin VV
    Ter Arkh; 2017; 89(8):120-128. PubMed ID: 28914862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course?
    Barrea L; Muscogiuri G; Annunziata G; Laudisio D; Pugliese G; Salzano C; Colao A; Savastano S
    Hormones (Athens); 2019 Sep; 18(3):245-250. PubMed ID: 30840230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gut microbiota and aging-A focus on centenarians.
    Cӑtoi AF; Corina A; Katsiki N; Vodnar DC; Andreicuț AD; Stoian AP; Rizzo M; Pérez-Martínez P
    Biochim Biophys Acta Mol Basis Dis; 2020 Jul; 1866(7):165765. PubMed ID: 32169505
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy.
    Ma J; Zhou Q; Li H
    Nutrients; 2017 Oct; 9(10):. PubMed ID: 29035308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Role of the Gut Microbiome in Predicting Response to Diet and the Development of Precision Nutrition Models-Part I: Overview of Current Methods.
    Hughes RL; Marco ML; Hughes JP; Keim NL; Kable ME
    Adv Nutr; 2019 Nov; 10(6):953-978. PubMed ID: 31225589
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gut Microbiota, Probiotics and Physical Performance in Athletes and Physically Active Individuals.
    Marttinen M; Ala-Jaakkola R; Laitila A; Lehtinen MJ
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32992765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The gut microbiome: what the oncologist ought to know.
    Lee KA; Luong MK; Shaw H; Nathan P; Bataille V; Spector TD
    Br J Cancer; 2021 Oct; 125(9):1197-1209. PubMed ID: 34262150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Feeding the microbiota: transducer of nutrient signals for the host.
    Shanahan F; van Sinderen D; O'Toole PW; Stanton C
    Gut; 2017 Sep; 66(9):1709-1717. PubMed ID: 28663354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.